Cargando…
Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318464/ https://www.ncbi.nlm.nih.gov/pubmed/32591025 http://dx.doi.org/10.1186/s13075-020-02256-2 |
| _version_ | 1783550858434183168 |
|---|---|
| author | Nived, Per Jönsson, Göran Settergren, Bo Einarsson, Jon Olofsson, Tor Jørgensen, Charlotte Sværke Skattum, Lillemor Kapetanovic, Meliha C. |
| author_facet | Nived, Per Jönsson, Göran Settergren, Bo Einarsson, Jon Olofsson, Tor Jørgensen, Charlotte Sværke Skattum, Lillemor Kapetanovic, Meliha C. |
| author_sort | Nived, Per |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7318464 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73184642020-06-29 Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients Nived, Per Jönsson, Göran Settergren, Bo Einarsson, Jon Olofsson, Tor Jørgensen, Charlotte Sværke Skattum, Lillemor Kapetanovic, Meliha C. Arthritis Res Ther Correction BioMed Central 2020-06-26 2020 /pmc/articles/PMC7318464/ /pubmed/32591025 http://dx.doi.org/10.1186/s13075-020-02256-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Nived, Per Jönsson, Göran Settergren, Bo Einarsson, Jon Olofsson, Tor Jørgensen, Charlotte Sværke Skattum, Lillemor Kapetanovic, Meliha C. Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients |
| title | Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients |
| title_full | Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients |
| title_fullStr | Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients |
| title_full_unstemmed | Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients |
| title_short | Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients |
| title_sort | correction to: prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional dmards, to some extent in abatacept but not in rituximab-treated patients |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318464/ https://www.ncbi.nlm.nih.gov/pubmed/32591025 http://dx.doi.org/10.1186/s13075-020-02256-2 |
| work_keys_str_mv | AT nivedper correctiontoprimeboostvaccinationstrategyenhancesimmunogenicitycomparedtosinglepneumococcalconjugatevaccinationinpatientsreceivingconventionaldmardstosomeextentinabataceptbutnotinrituximabtreatedpatients AT jonssongoran correctiontoprimeboostvaccinationstrategyenhancesimmunogenicitycomparedtosinglepneumococcalconjugatevaccinationinpatientsreceivingconventionaldmardstosomeextentinabataceptbutnotinrituximabtreatedpatients AT settergrenbo correctiontoprimeboostvaccinationstrategyenhancesimmunogenicitycomparedtosinglepneumococcalconjugatevaccinationinpatientsreceivingconventionaldmardstosomeextentinabataceptbutnotinrituximabtreatedpatients AT einarssonjon correctiontoprimeboostvaccinationstrategyenhancesimmunogenicitycomparedtosinglepneumococcalconjugatevaccinationinpatientsreceivingconventionaldmardstosomeextentinabataceptbutnotinrituximabtreatedpatients AT olofssontor correctiontoprimeboostvaccinationstrategyenhancesimmunogenicitycomparedtosinglepneumococcalconjugatevaccinationinpatientsreceivingconventionaldmardstosomeextentinabataceptbutnotinrituximabtreatedpatients AT jørgensencharlottesværke correctiontoprimeboostvaccinationstrategyenhancesimmunogenicitycomparedtosinglepneumococcalconjugatevaccinationinpatientsreceivingconventionaldmardstosomeextentinabataceptbutnotinrituximabtreatedpatients AT skattumlillemor correctiontoprimeboostvaccinationstrategyenhancesimmunogenicitycomparedtosinglepneumococcalconjugatevaccinationinpatientsreceivingconventionaldmardstosomeextentinabataceptbutnotinrituximabtreatedpatients AT kapetanovicmelihac correctiontoprimeboostvaccinationstrategyenhancesimmunogenicitycomparedtosinglepneumococcalconjugatevaccinationinpatientsreceivingconventionaldmardstosomeextentinabataceptbutnotinrituximabtreatedpatients |